Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dna X (SONM) Research & Development (2018 - 2025)

Historic Research & Development for Dna X (SONM) over the last 8 years, with Q3 2025 value amounting to $181000.0.

  • Dna X's Research & Development fell 7468.53% to $181000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $15.2 million, marking a year-over-year increase of 47385.08%. This contributed to the annual value of $14.2 million for FY2024, which is 70332.96% up from last year.
  • As of Q3 2025, Dna X's Research & Development stood at $181000.0, which was down 7468.53% from $909000.0 recorded in Q2 2025.
  • In the past 5 years, Dna X's Research & Development ranged from a high of $12.5 million in Q4 2024 and a low of -$135000.0 during Q3 2022
  • Its 5-year average for Research & Development is $2.5 million, with a median of $1.1 million in 2022.
  • Per our database at Business Quant, Dna X's Research & Development tumbled by 10245.81% in 2022 and then skyrocketed by 125064.79% in 2024.
  • Quarter analysis of 5 years shows Dna X's Research & Development stood at $3.9 million in 2021, then tumbled by 68.5% to $1.2 million in 2022, then dropped by 24.04% to $926000.0 in 2023, then skyrocketed by 1250.65% to $12.5 million in 2024, then crashed by 98.55% to $181000.0 in 2025.
  • Its Research & Development stands at $181000.0 for Q3 2025, versus $909000.0 for Q2 2025 and $1.6 million for Q1 2025.